ADCYAP1 | Adenylate cyclase activating polypeptide 1 (pituitary) | Predicted secreted proteins
| | | | | Tissue enhanced |
CASS4 | Cas scaffolding protein family member 4 | Cytoskeleton related proteins Plasma proteins
| | | | | Tissue enhanced |
CCL17 | Chemokine (C-C motif) ligand 17 | Predicted secreted proteins
| | | | | Tissue enhanced |
CCL19 | Chemokine (C-C motif) ligand 19 | Cancer-related genes Predicted secreted proteins
| | | | | Tissue enhanced |
CCL22 | Chemokine (C-C motif) ligand 22 | Predicted secreted proteins
| | | | | Tissue enhanced |
CCR2 | Chemokine (C-C motif) receptor 2 | CD markers G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
CCR4 | Chemokine (C-C motif) receptor 4 | CD markers G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
CD300E | CD300e molecule | CD markers Predicted membrane proteins
| | | | | Tissue enhanced |
CD300LB | CD300 molecule-like family member b | CD markers Predicted membrane proteins
| | | | | Tissue enhanced |
CEACAM3 | Carcinoembryonic antigen-related cell adhesion molecule 3 | CD markers Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CHI3L2 | Chitinase 3-like 2 | Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CLEC4A | C-type lectin domain family 4, member A | Predicted membrane proteins
| | | | | Tissue enhanced |
CLEC4E | C-type lectin domain family 4, member E | Predicted membrane proteins
| | | | | Tissue enhanced |
CLEC6A | C-type lectin domain family 6, member A | Predicted membrane proteins
| | | | | Tissue enhanced |
CLEC7A | C-type lectin domain family 7, member A | Disease related genes Predicted membrane proteins
| | | | | Tissue enhanced |
CR1 | Complement component (3b/4b) receptor 1 (Knops blood group) | Blood group antigen proteins CD markers Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CRLF2 | Cytokine receptor-like factor 2 | Cancer-related genes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CSF3 | Colony stimulating factor 3 (granulocyte) | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CTD-3088G3.8 | Protein LOC388210 | | | | | | Tissue enhanced |
CTLA4 | Cytotoxic T-lymphocyte-associated protein 4 | CD markers Disease related genes FDA approved drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CXCL10 | Chemokine (C-X-C motif) ligand 10 | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CXCL5 | Chemokine (C-X-C motif) ligand 5 | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CXCR1 | Chemokine (C-X-C motif) receptor 1 | Cancer-related genes CD markers G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
CXCR2 | Chemokine (C-X-C motif) receptor 2 | Cancer-related genes CD markers G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
EMR2 | Egf-like module containing, mucin-like, hormone receptor-like 2 | CD markers G-protein coupled receptors Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
EMR3 | Egf-like module containing, mucin-like, hormone receptor-like 3 | G-protein coupled receptors Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
FCGR1A | Fc fragment of IgG, high affinity Ia, receptor (CD64) | CD markers FDA approved drug targets Predicted membrane proteins
| | | | | Tissue enhanced |
FCGR1B | Fc fragment of IgG, high affinity Ib, receptor (CD64) | FDA approved drug targets Predicted membrane proteins
| | | | | Tissue enhanced |
FCGR3B | Fc fragment of IgG, low affinity IIIb, receptor (CD16b) | CD markers FDA approved drug targets Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
FFAR2 | Free fatty acid receptor 2 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
FFAR3 | Free fatty acid receptor 3 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
FOXP3 | Forkhead box P3 | Disease related genes Transcription factors
| | | | | Tissue enhanced |
FPR1 | Formyl peptide receptor 1 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
FPR2 | Formyl peptide receptor 2 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
FYB | FYN binding protein | | | | | | Tissue enhanced |
GAL | Galanin/GMAP prepropeptide | Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
GAPT | GRB2-binding adaptor protein, transmembrane | | | | | | Tissue enhanced |
GBP5 | Guanylate binding protein 5 | | | | | | Tissue enhanced |
GPR84 | G protein-coupled receptor 84 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
HCK | Hemopoietic cell kinase | Disease related genes Enzymes Potential drug targets
| | | | | Tissue enhanced |
IL11 | Interleukin 11 | Cancer-related genes Predicted secreted proteins
| | | | | Tissue enhanced |
IL4I1 | Interleukin 4 induced 1 | Enzymes Predicted secreted proteins
| | | | | Tissue enhanced |
IL7R | Interleukin 7 receptor | Cancer-related genes CD markers Disease related genes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ITGAX | Integrin, alpha X (complement component 3 receptor 4 subunit) | CD markers Predicted membrane proteins
| | | | | Tissue enhanced |
JAK3 | Janus kinase 3 | Cancer-related genes Cytoskeleton related proteins Disease related genes Enzymes FDA approved drug targets
| | | | | Tissue enhanced |
LILRA1 | Leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 1 | CD markers Predicted membrane proteins
| | | | | Tissue enhanced |
LILRA3 | Leukocyte immunoglobulin-like receptor, subfamily A (without TM domain), member 3 | CD markers Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
LILRA5 | Leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 5 | CD markers Predicted membrane proteins
| | | | | Tissue enhanced |
LILRA6 | Leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6 | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
LILRB1 | Leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 1 | CD markers Predicted membrane proteins
| | | | | Tissue enhanced |